These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 25059005)

  • 21. New anticoagulant drugs among elderly patients is caution necessary?: Comment on "The use of dabigatran in elderly patients".
    Jacobs JM; Stessman J
    Arch Intern Med; 2011 Jul; 171(14):1287-8. PubMed ID: 21788546
    [No Abstract]   [Full Text] [Related]  

  • 22. Initial experience with dabigatran etexilate at Auckland City Hospital.
    Bell S; Nand J; Spriggs D; Young L; Dawes M
    N Z Med J; 2012 Feb; 125(1349):105-7. PubMed ID: 22327149
    [No Abstract]   [Full Text] [Related]  

  • 23. Treatments for stroke prevention in atrial fibrillation: a network meta-analysis and indirect comparisons versus dabigatran etexilate.
    Roskell NS; Lip GY; Noack H; Clemens A; Plumb JM
    Thromb Haemost; 2010 Dec; 104(6):1106-15. PubMed ID: 20967400
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma dabigatran activity one week after discontinuation despite normal renal function.
    Thachil J; Pike G; Keighley-Jones L; Nash MJ
    Am J Med; 2013 Aug; 126(8):e5-6. PubMed ID: 23800582
    [No Abstract]   [Full Text] [Related]  

  • 25. Comment on ''gastrointestinal bleeding under dabigatran''.
    Gélisse P; Crespel A
    J Postgrad Med; 2014; 60(4):413-4. PubMed ID: 25370556
    [No Abstract]   [Full Text] [Related]  

  • 26. When dabigatran and trauma collide.
    Huang GS; Chance EA
    Am Surg; 2013 Jan; 79(1):113-4. PubMed ID: 23317625
    [No Abstract]   [Full Text] [Related]  

  • 27. The pharmacology and therapeutic use of dabigatran etexilate.
    Sarah S
    J Clin Pharmacol; 2013 Jan; 53(1):1-13. PubMed ID: 23400738
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparison of results of the US food and drug administration's mini-sentinel program with randomized clinical trials: the case of gastrointestinal tract bleeding with dabigatran.
    Sipahi I; Celik S; Tozun N
    JAMA Intern Med; 2014 Jan; 174(1):150-1. PubMed ID: 24247291
    [No Abstract]   [Full Text] [Related]  

  • 29. Direct thrombin inhibitors: a case indicating benefit from 'plasmapheresis' in toxicity: a call for establishing "guidelines" in overdose and to find an "antidote"!
    Kamboj J; Kottalgi M; Cirra VR; Shah N; Kamboj R
    Am J Ther; 2012 Nov; 19(6):e182-5. PubMed ID: 23154229
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiple data sources, the best way to gather safety information about medications.
    Katz MH
    JAMA Intern Med; 2014 Jan; 174(1):151. PubMed ID: 24248326
    [No Abstract]   [Full Text] [Related]  

  • 31. Dabigatran etexilate: another double-edged drug? : editorial to: "the beneficial effects of a direct thrombin inhibitor, dabigatran etexilate, on the development and stability of atherosclerotic lesions in apolipoprotein E-deficient mice" by N. Kadoglou et al.
    Laguna JC; Alegret M
    Cardiovasc Drugs Ther; 2012 Oct; 26(5):361-4. PubMed ID: 22986913
    [No Abstract]   [Full Text] [Related]  

  • 32. Activated prothrombin complex concentrate for dabigatran-associated bleeding.
    Schulman S; Ritchie B; Goy JK; Nahirniak S; Almutawa M; Ghanny S
    Br J Haematol; 2014 Jan; 164(2):308-10. PubMed ID: 24383848
    [No Abstract]   [Full Text] [Related]  

  • 33. Dabigatran in clinical practice.
    Nagarakanti R; Ellis CR
    Clin Ther; 2012 Oct; 34(10):2051-60. PubMed ID: 23031622
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dabigatran: comparison to warfarin, pathway to approval, and practical guidelines for use.
    Iyer V; Singh HS; Reiffel JA
    J Cardiovasc Pharmacol Ther; 2012 Sep; 17(3):237-47. PubMed ID: 22388002
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Namibia becomes first country in Africa to launch dabigatran etexilate for atrial fibrillation.
    Wagenaar P
    Cardiovasc J Afr; 2011; 22(5):283. PubMed ID: 21983957
    [No Abstract]   [Full Text] [Related]  

  • 36. Dabigatran etexilate for prevention of venous thromboembolism.
    Eikelboom JE; Weitz JI
    Thromb Haemost; 2009 Jan; 101(1):2-4. PubMed ID: 19132179
    [No Abstract]   [Full Text] [Related]  

  • 37. Thromboembolic prophylaxis in orthopedic surgery using dabigatran: an oral direct thrombin inhibitor.
    Garza R; Huo MH
    Expert Rev Cardiovasc Ther; 2012 Apr; 10(4):423-7. PubMed ID: 22458575
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hemorrhagic complications of direct thrombin inhibitors-subarachnoid hemorrhage during dermabrasion for scar revision.
    Fakhouri TM; Harmon CB
    Dermatol Surg; 2013 Sep; 39(9):1410-2. PubMed ID: 23796048
    [No Abstract]   [Full Text] [Related]  

  • 39. [New anticoagulants. A warning shot!].
    Fiessinger JN
    Rev Prat; 2013 Feb; 63(2):151. PubMed ID: 23513767
    [No Abstract]   [Full Text] [Related]  

  • 40. [Pharmacological and clinical profiles of the direct thrombin inhibitor dabigatran etexilate methane sulfate (Prazaxa(®)) ].
    Ohmura T; Takahashi I; Ikegami K; Encinas J
    Nihon Yakurigaku Zasshi; 2011 Aug; 138(2):79-88. PubMed ID: 21828942
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.